Gensaic, Inc., a biotechnology company that combines AI-powered protein design with biological insights to discover ligands for tissue-selective intracellular delivery, announced a license and...
IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced a research collaboration with ATTMOS as...
Magnet Biomedicine, a leading biopharmaceutical company advancing molecular glue discovery with rational selection and design, announced a collaboration and license agreement with Eli Lilly...
EpiVax, Inc. is proud to announce the appointment of Guilhem Richard as Chief Technology Officer. Dr. Richard joined EpiVax's Immunoinformatics team in 2014 and led the...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
